Our Company l News & Events

IIkonisys names Paul White Chief Financial Officer & VP of Business Development

New Haven, Conn., March 20, 2006:

Ikonisys Inc., a leading developer of cell-based diagnostic products, today announced that Paul White, an accomplished financial and business development executive with broad technology experience, has joined the company as its chief financial officer and vice president of business development. Mr. White joins Ikonisys at its New Haven, CT headquarters from global VoIP provider deltathree, Inc., (Nasdaq:DDDC) where, as CFO and EVP - Strategy, Development & Planning, he led the company to its most recent record year and achievement of profitability.

Paul White is an accomplished and experienced professional with an impressive track record in global, growth-oriented technology companies," said Ikonisys Chairman and CEO Petros Tsipouras. "Paul's leadership, financial and business development expertise have repeatedly enabled emerging companies to attain profitability and achieve successful equity events. As a key member of our management team, Paul's experience and expertise will be instrumental in Ikonisys continued success in both domestic and international markets. We are excited to have him join our team and continue to enhance our capabilities."

It was under Mr. White's stewardship as CFO at deltathree, Inc. that the company experienced approximately six years of significant top-line and bottom-line growth, and, ultimately, profitability. Mr. White has also held senior finance and/or business development level positions with Tangoe Inc., Buyersedge.com, AT&T's SNET subsidiary, Ernst & Young, LLP and Arthur Andersen, LLP. Mr. White has a BBA and an MBA from Hofstra University, and is a Certified Public Accountant.

About Ikonisys
Ikonisys, a global leader in the development of cell-based diagnostic products has developed a platform of robotic microscopy. Based on its proprietary technology, Ikonisys aims to expand the novel field of cell-based diagnostics with products in the genetic disease, oncology, and fertility areas. Additional information about Ikonisys can be found at www.ikonisys.com.